Feng Dingqing, Peng Cheng, Li Cairong, Zhou Ying, Li Min, Ling Bin, Wei Haiming, Tian Zhigang
Anhui Province Key Laboratory of Molecular Medicine, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, PR China.
Oncol Rep. 2009 Nov;22(5):1129-34. doi: 10.3892/or_00000545.
Like many other solid tumors, cervical cancer contains a heterogeneous population of cancer cells. Several investigators have identified putative stem cells from solid tumors and cancer cell lines via the capacity to self renew and drive tumor formation. The aim of this study was to identify and characterize a cancer stem-like cell population from primary carcinoma of the cervix uteri. Cervical carcinoma from 19 patients staged I-II following International Federation of Gynecology and Obstetrics (FIGO) criteria were disaggregated and subjected to growth conditions selective for stem cells. Eight of nineteen tumor-derived cultures encompassed stem-like cells capable of self-renewal, extensive proliferation as clonal non-adherent spherical clusters. Cell markers of spheroid were identified as CD44+CK17+. Cell survival assays showed the sphere-forming cells were only 48% inhibited by doxorubicin whereas 78% inhibited by paclitaxel. Chemo-resistance may partly attribute to the exclusive expression of ABC transporter. To investigate the tumorigenicity of these stem-like cells, xenoengraftment of 10(5) dissociated spheroid cells allowed full recapitulation of the original tumor, whereas the same amount of tumor cells without non-adherent spheroid selection remained non-tumorigenic. Stemness properties of these spheroid cells were further established by reverse transcription-PCR and Western blotting, demonstrating the expression of embryonic and adult stemness-related genes (Oct-4, Piwil2, C-myc, Stat3 and Sox2). Based on these findings, we assert that cervical cancer contain a subpopulation of tumor initiating cells with stem-like properties, thus facilitating the approach to therapeutic strategies aimed at eradicating the tumorigenic subpopulation within cervical cancer.
与许多其他实体瘤一样,宫颈癌包含异质性的癌细胞群体。一些研究人员已通过自我更新能力和驱动肿瘤形成的能力,从实体瘤和癌细胞系中鉴定出假定的干细胞。本研究的目的是从子宫颈原发性癌中鉴定并表征具有癌症干细胞样特性的细胞群体。按照国际妇产科联盟(FIGO)标准,对19例I-II期宫颈癌患者的肿瘤进行解离,并使其处于对干细胞有选择性的生长条件下。19个肿瘤来源的培养物中有8个包含能够自我更新的干细胞样细胞,这些细胞可作为克隆性非贴壁球形簇进行广泛增殖。球形细胞的细胞标志物被鉴定为CD44+CK17+。细胞存活试验表明,阿霉素仅能抑制48%的成球细胞,而紫杉醇能抑制78%的成球细胞。化疗耐药性可能部分归因于ABC转运蛋白的特异性表达。为了研究这些干细胞样细胞的致瘤性,将10(5)个解离的球形细胞进行异种移植,可完全重现原始肿瘤,而同样数量未经非贴壁球形细胞筛选的肿瘤细胞仍无致瘤性。通过逆转录-聚合酶链反应(RT-PCR)和蛋白质免疫印迹法进一步证实了这些球形细胞具有干性特性,表明其表达胚胎和成人干性相关基因(Oct-4、Piwil2、C-myc、Stat3和Sox2)。基于这些发现,我们断言宫颈癌包含具有干细胞样特性的肿瘤起始细胞亚群,从而有助于制定旨在根除宫颈癌中致瘤亚群的治疗策略。